The collaboration focuses on personalized medicine in the capital of the United Arab Emirates.
United Arab Emirates (UAE) Healthcare Regulatory Council – Abu Dhabi’s Department of Health has announced an agreement with AbbVie Biopharmaceutical and integrated healthcare company M42 to work on genomics for personalized medicine in the city. As part of the partnership, the three parties intend to advance the diagnosis and treatment of multiple myeloma and non-small cell lung cancer.
Hassan Sabbah, General Manager, AbbVie Gulf and Levant, said: “This partnership aims to advance precision medicine in diagnostics and therapeutics, and to improve access to innovative treatments for a wider range of patients in the UAE. We are Efforts to launch multiple research-supporting initiatives and clinical trials and develop innovative solutions to effectively address local and regional health needs, challenges and burdens.”
refer to: Abu Dhabi Department of Health, M42 and AbbVie form strategic partnership to advance personalized medicine and genomics. June 19, 2023. Accessed June 21, 2023. https://www.prnewswire.com/news-releases/department-of-health–abu-dhabi-m42-and-abbvie-enter-a-strategic-partnership-to-advance-personalized-medicine-and-genomics -301854543.html